Zobrazeno 1 - 10
of 178
pro vyhledávání: '"Narek, Shaverdian"'
Autor:
Basil H. Chaballout, Eric M. Chang, Narek Shaverdian, Percy P. Lee, Phillip J. Beron, Michael L. Steinberg, Ann C. Raldow
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19978-19986 (2023)
Abstract Background The aim of this study was to compare patient perceptions of radiotherapy (RT) before and after treatment to better inform future patients and providers. Methods Seventy‐eight consecutive patients with rectal adenocarcinoma treat
Externí odkaz:
https://doaj.org/article/5f4f019916b94608bf530c6bc25f4bf7
Autor:
Joao V. Alessi, Biagio Ricciuti, Xinan Wang, Federica Pecci, Alessandro Di Federico, Giuseppe Lamberti, Arielle Elkrief, Scott J. Rodig, Emily S. Lebow, Jordan E. Eicholz, Maria Thor, Andreas Rimner, Adam J. Schoenfeld, Jamie E. Chaft, Bruce E. Johnson, Daniel R. Gomez, Mark M. Awad, Narek Shaverdian
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract Although concurrent chemoradiation (CRT) and durvalumab consolidation has become a standard treatment for stage III non-small cell lung cancer (NSCLC), clinicopathologic and genomic factors associated with its efficacy remain poorly characte
Externí odkaz:
https://doaj.org/article/1cb0d71dba954b7a82afb042b77b3eda
Autor:
Basil H. Chaballout, Eric M. Chang, Narek Shaverdian, Percy P. Lee, Phillip J. Beron, Michael L. Steinberg, Ann C. Raldow
Publikováno v:
Cancer Reports, Vol 6, Iss 12, Pp n/a-n/a (2023)
Abstract Background Little is known regarding anal cancer patients' perspectives on undergoing radiation therapy. Additionally, the stigma surrounding anal cancer diagnosis warrants a better understanding of the barriers to complete disclosure in pat
Externí odkaz:
https://doaj.org/article/170d63130f0540529459ac8e9e7f0336
Autor:
Biagio Ricciuti, Joao V Alessi, Mark M Awad, Arielle Elkrief, Jamie E Chaft, Bruce E Johnson, Xinan Wang, Allison L Richards, Federica Pecci, Alessandro Di Federico, Adam J Schoenfeld, Malini M Gandhi, Adam Price, Emily S Lebow, Patricia Mae G Santos, Maria Thor, Andreas Rimner, Daniel R Gomez, Narek Shaverdian
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)
There is a need to identify predictive biomarkers to guide treatment strategies in stage III non-small cell lung cancer (NSCLCs). In this multi-institutional cohort of 197 patients with stage III NSCLC treated with concurrent chemoradiation (cCRT) an
Externí odkaz:
https://doaj.org/article/13b34cc4df014ca0bde4aed8a337931d
Autor:
Emily S. Lebow, Narek Shaverdian, Jordan E. Eichholz, Leah B. Kratochvil, Megan McCune, Yonina R. Murciano-Goroff, Justin Jee, Juliana Eng, Jamie E. Chaft, Mark G. Kris, Ekaterina Kalashnikova, Jordan Feeney, Carly Bess Scalise, Sumedha Sudhaman, Charuta C. Palsuledesai, Meenakshi Malhotra, Michael Krainock, Himanshu Sethi, Alexey Aleshin, Minetta C. Liu, Annemarie F. Shepherd, Abraham J. Wu, Charles B. Simone, Daphna Y. Gelblum, Kaylie A. Johnson, Charles M. Rudin, Daniel R. Gomez, Pedram Razavi, Jorge S. Reis-Filho, James M. Isbell, Bob T. Li, Andreas Rimner
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundSensitive and reliable biomarkers for early detection of recurrence are needed to improve post-definitive radiation risk stratification, disease management, and outcomes for patients with unresectable early-stage or locally advanced non-sma
Externí odkaz:
https://doaj.org/article/3ba4f11343744c078451496fafdf072c
Autor:
Justin M. Haseltine, Aditya Apte, Andrew Jackson, Ellen Yorke, Anthony F. Yu, Andrew Plodkowski, Abraham Wu, Ariel Peleg, Mohammed Al-Sadawi, Michelle Iocolano, Daphna Gelblum, Narek Shaverdian, Charles B. Simone, II, Andreas Rimner, Daniel R. Gomez, Annemarie F. Shepherd, Maria Thor
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 25, Iss , Pp 100410- (2023)
Background and purpose: Coronary calcifications are associated with coronary artery disease in patients undergoing radiotherapy (RT) for non-small cell lung cancer (NSCLC). We quantified calcifications in the coronary arteries and aorta and investiga
Externí odkaz:
https://doaj.org/article/9d88fd10a5e2409cb13dd827eed71d21
Autor:
Narek Shaverdian, Maria Thor, Annemarie F. Shepherd, Michael D. Offin, Andrew Jackson, Abraham J. Wu, Daphna Y. Gelblum, Ellen D. Yorke, Charles B. Simone II, Jamie E. Chaft, Matthew D. Hellmann, Daniel R. Gomez, Andreas Rimner, Joseph O. Deasy
Publikováno v:
Cancer Medicine, Vol 9, Iss 13, Pp 4622-4631 (2020)
Abstract Introduction Durvalumab after concurrent chemoradiation (cCRT) is now standard of care for unresected stage III non–small cell lung cancer (NSCLC). However, there is limited data on radiation pneumonitis (RP) with this regimen. Therefore,
Externí odkaz:
https://doaj.org/article/50d800fc23384e0fb29bee7b87b27705
Autor:
Annemarie F. Shepherd, MD, Anthony F. Yu, MD, Michelle Iocolano, MD, Jonathan E. Leeman, MD, Aaron T. Wild, MD, Brandon S. Imber, MD, MA, Jamie E. Chaft, MD, Michael Offin, MD, James Huang, MD, James M. Isbell, MD, MSCI, Abraham J. Wu, MD, Daphna Y. Gelblum, MD, Narek Shaverdian, MD, Charles B. Simone, II, MD, Daniel Gomez, MD, Ellen Yorke, PhD, Andrew Jackson, PhD, Andreas Rimner, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 8, Pp 100209- (2021)
Introduction: Given the concern for cardiopulmonary toxicity in patients with NSCLC undergoing postoperative radiation therapy (PORT), the purpose of this study was to evaluate the association between heart dose and overall survival (OS) in patients
Externí odkaz:
https://doaj.org/article/aae79c56f33a4e87b7bc7fe74e987c31
Autor:
Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M. Muldoon, Arrien A. Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R. Vaz, Malini Gandhi, Elinton Lee, Geoffrey I. Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D. Felt, Bijaya Sharma, Andrew D. Cherniack, Scott Rodig, Daniel R. Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A. Janne, Adam J. Schoenfeld, Lynette M. Sholl, Mark M. Awad, Michael L. Cheng
Publikováno v:
Clinical Cancer Research. :OF1-OF11
Purpose: ATM is the most commonly mutated DNA damage and repair gene in non–small cell lung cancer (NSCLC); however, limited characterization has been pursued. Experimental Design: Clinicopathologic, genomic, and treatment data were collected for 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62451ff0a5df3fbff60cb7bb3f125bba
https://doi.org/10.1158/1078-0432.ccr-22-3413
https://doi.org/10.1158/1078-0432.ccr-22-3413
Autor:
Narek Shaverdian, MD, Michael Offin, MD, Annemarie F. Shepherd, MD, Matthew D. Hellmann, MD, Daniel R. Gomez, MD, Jamie E. Chaft, MD, Andreas Rimner, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 7, Pp 100197- (2021)
Introduction: Durvalumab after concurrent chemoradiation (cCRT) has been found to improve outcomes of patients with unresected stage III NSCLC. However, the survival impact of discontinuing durvalumab early owing to adverse events (AEs) remains unkno
Externí odkaz:
https://doaj.org/article/543a52e006f54f02a1a7c6515b7f698f